bivalent EV71/CA16 vaccine (Zhejiang Pukang Biotechnology)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebivalent EV71/CA16 vaccine (Zhejiang Pukang Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Inactivated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsEnterovirus 71 infectionCoxsackievirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesZhejiang Pukang Biologic Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZhejiang Pukang Biologic Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsEnterovirus 71 infectionCoxsackievirus Infections

Other Information

ATC CodeN/A
Related LinksN/A